IMS site is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
1st – 3rd March 2023 Novotel Hotel Mumbai International Airport
General Manager - Global IPZydus Cadila
Former Chairman In-Charge & Technical Member-Patents Intellectual Property Appellate Board (IPAB) Department for Promotion of Industry and Internal TrMinistry of Commerce and Industry, Government of India.
Head of Intellectual PropertyIndia, Novozymes
Head & Associate Vice President-Business DevelopmentPortfolio & Strategy, Kashiv BioSciences LLC
Global General Counsel Dr. Reddy's Laboratories
Sr Regional Manager and Head (IPFC & TISC)National Research Development Corporation (DSIR Enterprise, Ministry of S&T, Govt. of India)
SHAREHOLDERMaynard's New York
LawyerPharmaceuticals, Chemicals and Biotechnology
Founding PartnerEsq., Pergament & Cepeda LLP
Head & Patent Counsel Intellectual Property ManagementUnichem labs
United States Intellectual Property Counselor for South AsiaUnited States Department of Commerce
Partner and Head IP of Patent – Design - Copyright DepartmentUnited Trademark & Patent Services
Director, Head - IPR departmentNeuland Laboratories Limited
Sr. Director (Head) – IPFresenius Kabi
Vice President & Head – Global PortfolioBD & IP, Granules India Limited
General Manager - Global IP
Former Chairman In-Charge & Technical Member-Patents Intellectual Property Appellate Board (IPAB) Department for Promotion of Industry and Internal Tr
Ministry of Commerce and Industry, Government of India.
Head of Intellectual Property
Head & Associate Vice President-Business Development
Portfolio & Strategy, Kashiv BioSciences LLC
Global General Counsel
Dr. Reddy's Laboratories
Sr Regional Manager and Head (IPFC & TISC)
National Research Development Corporation (DSIR Enterprise, Ministry of S&T, Govt. of India)
Maynard's New York
Chris Harnett, a Shareholder in Maynard's New York Office, focuses his
practice on the litigation of intellectual property matters. Over the past
three decades, Chris has litigated cases in more than 35 jurisdictions
around the country, prevailing for clients at the pleadings stage, during
claim construction, in securing and opposing preliminary injunctive relief,
on summary judgment, at bench and jury trials, and after appellate review.
Those cases involved a wide range of technologies, including
pharmaceuticals, biotechnology, medical devices, computer systems,
and consumer products.
Chris works closely with clients to develop integrated legal and business-
focused strategies that best serve their needs, relying on his strong
background in science and his litigation expertise. A registered patent
attorney, Chris also represents clients in IPR proceedings and assists
clients in managing their patent portfolios and in evaluating the
competitive patent landscape in anticipation of potential litigation.
After graduating from the Georgetown University Law Center in 1990,
Chris began his career at the preeminent intellectual property law firm,
Fish & Neave, where he was a Partner for many years.
Notable Cases and Successes
Pharmaceuticals, Chemicals and Biotechnology
Esq., Pergament & Cepeda LLP
Mr. Pergament litigates patent infringement actions and drafts patent opinions for a variety of pharmaceutical clients from India, China, Russia, and North America. Mr. Pergament primary expertise is in positioning pharmaceutical assets versus patent portfolios, both offensively and defensively, by any means available under the law, including patent litigation, patent strategy considerations, and patent procurement. Mr. Pergament has a broad legal, business and technical expertise in pharmaceutical and cosmetic industry. At present, Mr. Pergament’s practice is focused mainly on pharmaceutical patent litigation and establishing litigation positions for generic pharmaceutical companies, and on counseling brand side clients in pharmaceutical and chemical industries with respect to life cycle management and other strategic issues, including portfolio management. Mr. Pergament was a scientist, an attorney, and an executive with several major pharmaceutical companies, and he has hand-on understanding of legal, business, and technical issues facing a broad range of pharmaceutical products, including NCEs, specialty, generics, formulations, and pharmaceutical solids.
Admissions: New York, 2000, New Jersey, 2001; U.S. Court of Appeals for the Federal Circuit; registered to practice before U.S. Patent and Trademark Office (1997).
Education: University of Odessa, former USSR (B.Sc., Chemistry/Organic Chemistry, 1985); Case Western Reserve University (M.Sc., Chemistry/Organic Chemistry, 1993); Rutgers School of Law, cum laude, Order of the Coif (J.D., 1999).
Practice Areas: Pharmaceutical Patent Litigation, Pharmaceutical Patent Law, and Counseling
Head & Patent Counsel Intellectual Property Management
United States Intellectual Property Counselor for South Asia
United States Department of Commerce
Partner and Head IP of Patent – Design - Copyright Department
United Trademark & Patent Services
Director, Head - IPR department
Neuland Laboratories Limited
Sr. Director (Head) – IP
Vice President & Head – Global Portfolio
BD & IP, Granules India Limited